Cui et al. showed that miR-186 overexpression significantly suppressed the malignant phenotype of Hepatoblastoma cells, and methyltransferase-like 3 (METTL3) inhibited this miR-186 overexpression. This evidence concerns the gene METTL3 and hepatoblastoma.